AI assistant
Wave Life Sciences Ltd. — Director's Dealing 2025
Aug 14, 2025
31900_dirs_2025-08-13_d319b223-7199-4ab2-bdaf-0450d05b4e3f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Wave Life Sciences Ltd. (WVE)
CIK: 0001631574
Period of Report: 2025-08-11
Reporting Person: Tan Aik Na (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-08-11 | Ordinary Shares | A | 25400 | $0.00 | Acquired | 40388 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-08-11 | Share Option (right to buy) | $8.105 | A | 152400 | Acquired | 2030-08-11 | Ordinary Shares (152400) | Direct |
Footnotes
F1: The reporting person was granted this restricted share unit award (RSU) pursuant to the 2025 Non-Employee Director Compensation Policy. The RSU vests as to 50% on each of (i) the earlier of the Company's 2026 annual general meeting or August 11, 2026; and (ii) the earlier of the Company's 2027 annual general meeting or August 11, 2027.
F2: The reporting person was granted this option pursuant to the 2025 Non-Employee Director Compensation Policy. The option vests as to 12.5% on a quarterly basis beginning August 11, 2025, through the two-year period following the grant date.